MBMarta BoffitoMD, PhD, FRCP, MBASlidesetHIVHIV Clinical Forum 2015Pharmacological considerations - Marta Boffito, MD, PhD, FRCPView Slideset
SlidesetHIVHIV Clinical Forum 2015Basic Science of Integrase Inhibitors - François Clavel, MDView Slideset
CBCharles BoucherMD, PhDSlidesetHIVHIV Clinical Forum 2015Resistance characteristics of Integrase Inhibitors - Charles Boucher, MD, PhDView Slideset
LWLaura WatersMD, FRCPSlidesetHIVLeveraging Reverse Transcriptase in HIV 2021RTI 2021 - Laura Waters - Clinical Review: New RT Inhibitors – DoravirineView Slideset
GJMGraeme J. MoyleMD, MB BS, Dip. GUMSlidesetHIVLeveraging Reverse Transcriptase in HIV 2021RTI 2021 - Graeme J. Moyle - Remaining Gaps in Current HIV TherapyView Slideset
FVFrançois VenterMD, FCP, PhDSlidesetHIVLeveraging Reverse Transcriptase in HIV 2021RTI 2021 - François Venter - Clinical Review: New RT Inhibitors – IslatravirView Slideset
CFCharles FlexnerMDSlidesetHIVLeveraging Reverse Transcriptase in HIV 2021RTI 2021 - Charles Flexner - Clinical Pharmacology of Newer RT InhibitorsView Slideset
CFPCarlo Federico PernoMD, PhDSlidesetHIVLeveraging Reverse Transcriptase in HIV 2021RTI 2021 - Carlo Federico Perno - Mechanisms of Action: NRTI, NRTTI, and NNRTIView Slideset
